Shanghai Innostar Biotechnology Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Innostar Biotechnology has a total shareholder equity of CN¥2.4B and total debt of CN¥8.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥3.3B and CN¥878.0M respectively. Shanghai Innostar Biotechnology's EBIT is CN¥148.3M making its interest coverage ratio -19.3. It has cash and short-term investments of CN¥1.5B.
Key information
0.3%
Debt to equity ratio
CN¥8.01m
Debt
| Interest coverage ratio | -19.3x |
| Cash | CN¥1.48b |
| Equity | CN¥2.39b |
| Total liabilities | CN¥878.03m |
| Total assets | CN¥3.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688710's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥631.5M).
Long Term Liabilities: 688710's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥246.5M).
Debt to Equity History and Analysis
Debt Level: 688710 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 688710's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 688710's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 688710 earns more interest than it pays, so coverage of interest payments is not a concern.